Pulse Biosciences Inc EV/EBITDA
¿Qué es el EV/EBITDA de Pulse Biosciences Inc?
El EV/EBITDA de Pulse Biosciences Inc es N/A
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Pulse Biosciences Inc
¿Qué hace Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Empresas con ev/ebitda similar a Pulse Biosciences Inc
- Terramin Australia tiene EV/EBITDA de N/A
- Danakali tiene EV/EBITDA de N/A
- Prospect Park Capital tiene EV/EBITDA de N/A
- Altura Mining tiene EV/EBITDA de N/A
- Redstar Gold tiene EV/EBITDA de N/A
- Aminex Plc tiene EV/EBITDA de N/A
- Pulse Biosciences Inc tiene EV/EBITDA de N/A
- Nova Cannabis tiene EV/EBITDA de N/A
- GT Gold tiene EV/EBITDA de N/A
- Nanoxplore Inc tiene EV/EBITDA de N/A
- Cervantes tiene EV/EBITDA de N/A
- SolGold Plc tiene EV/EBITDA de N/A
- Sailfish Royalty tiene EV/EBITDA de N/A